Over 20 years of experience in management consulting, private equity, corporate finance and executive management of technology, life sciences and business services companies. As a strategy consultant, Erik advised Big Pharma on market entry stategies for new drugs. He was involved with early stage life sciences investments across Europe as a Partner at Swiss VC firm Metellus and as Venture Partner in technology incubator Antfactory.
He is also a partner at VK Partners, a venture acceleration firm, which specialises in commercialising early stage technology and life science ventures.
Prior roles include: Partner of Metellus, board member of several of its ventures in Europe and USA. COO of Rebus, a global software firm backed by Warburg Pincus and General Atlantic. MD Business Services of FTSE listed Xchanging plc, a global outsourcing business (now a part of CSC). Strategy consultant at Monitor Company.
Erik holds masters degrees in Applied Physics and Business from Delft University of Technology, and studied Leading Change & Organisational Renewal at Stanford Graduate School of Business